EPFL BioE Talks SERIES "Mechanical Control of Cytotoxic Lymphocyte Function"


Event details

Date 22.11.2021
Hour 16:0017:00
Speaker Prof. Morgan Huse, Memorial Sloane Kettering Cancer Center (MSKCC), New York City, NY (USA)
Location Online
Category Conferences - Seminars
Event Language English

About the speaker and the talk:
Dr. Huse spent much of his childhood in East Asia before completing high school in Los Angeles. After graduating from Harvard University with a degree in Biochemical Sciences, he carried out doctoral work at the Rockefeller University, where he studied with John Kuriyan, Tom Muir, and Joan Massagué.  His thesis research focused on the phosphoregulation of the type I TGFβ receptor. After receiving his Ph.D., Dr. Huse worked as a postdoctoral fellow in Marc Davis’ lab at Stanford University, where he studied signal transduction and polarized effector responses in T cells. He took a position as assistant member in the Memorial Sloane Kettering Cancer Center (MSKCC) Immunology Program in 2007. Since then, his lab has focused on the structure and function of immune cell-cell interactions, particularly on how cytotoxic T lymphocytes and natural killer cells destroy malignant cancer cells. His work has touched upon key signaling pathways required for the elaboration of specific interfacial structures and the importance of mechanical force as an avenue for communication between immune cells. Today’s seminar will describe two ways in which the mechanical properties of the cytotoxic immune synapse control its function.

Zoom link (with one-time registration for the whole series) for attending remotely: https://go.epfl.ch/EPFLBioETalks

This seminar can be followed via Zoom web-streaming only, (following prior one-time registration through the link above).

Instructions for 1st-year Ph.D. students who are under EDBB’s mandatory seminar attendance rule:
Please make sure to
  1. send D. Reinhard a note before noon on seminar day, informing that you plan to attend the talk online, and
  2. be signed in on Zoom with a recognizable user name (not a pseudonym making it difficult or impossible to be identified).

Practical information

  • Informed public
  • Registration required